ORA
™
System, now featuring
VerifEye+
™
Technology
The ORA
™
System with new VerifEye+
™
Technology empowers decision making in the OR with
intraoperative data verification. When compared to conventional (preoperative) calculation of cylinder
power and axis, surgeons using the ORA
™
System with VerifEye+
™
Technology have reduced the number
of patients who fall outside the intended astigmatic target by almost 54%.
*,2
NOW WITH REAL-TIME DATA VERIFICATION IN YOUR OCULAR
Visit myalcon.com to learn more.
Advancing
CATARACT SURGERY
ORA
™
System
WITH VERIFEYE+
™
Please see adjacent page for Important Product Information.
*Intended target is defined as within 0.5 D of target astigmatism.
1. Ianchulev T, Hoffer K, Yoo S, et al. Intraoperative refractive biometry for predicting intraocular lens power calculation after prior myopic refractive surgery. Ophthalmology. 2014;121(1):57-60.
2. Alcon data on file. VerifEye+
™
Technology incorporates the VerifEye
®
Technology validation software, but VerifEye+
™
Technology was not available at the time of the study.
© 2015 Novartis 4/15 OR A15021JAD
Advancing
CATARACT SURGERY
ORA
™
System
WITH VERIFEYE+
™
Advancing
CATARACT SURGERY
ORA
™
System
WITH VERIFEYE+
™
Advancing
CATARACT SURGERY
ORA
™
System
WITH VERIFEYE+
™
Lens power, sphere, cylinder
and axis recommendation
Proven to significantly
increase accuracy of lens
power selection and decrease
prediction error in prior myopic
LASIK patients
1
Improved astigmatic outcomes
by accounting for posterior
corneal contribution
2
